FIT more cost-effective than colonoscopy for CRC screening

Despite some drawback, both annual and biennial fecal immunochemical tests are as effective at detecting colorectal cancer while being more cost-effective than colonoscopy every 10 years, according to results of a meta-analysis.“Compared with colonoscopy, FIT has poorer one-time performance for neoplastic detection but higher participation rates,” Guo-Chao Zhong, PhD, of the second Affiliated Hospital of Chongqing Medical University in China, and colleagues wrote. “Improved participation of FIT may offset its relatively poor detection capacity in population screening.Read More